Abstract

BackgroundPhage-display panning is an integral part of biomedical research. Regular panning methods are sometimes complicated by inefficient detachment of the captured phages from the antigen-coated solid supports, which prompted us to modify. Here, we produce an efficient antigen-specific single chain fragment variable (scFv) antibody by using a target-related molecule that favored selection ofrecombinant antibodies.ResultsTo produce more selective and specific anti-idiotypic scFv-antibodies from a cDNA library, constructed from HM-1 killer toxin (HM-1)-neutralizing monoclonal antibodies (nmAb-KT), the method was modified by using an elution buffer supplemented with HM-1 that shares structural and functional similarities with the active site of the scFv antibody. Competitive binding of HM-1 to nmAb-KT allowed easy and quick dissociation of scFv-displayed phages from immobilized nmAb-KT to select specific anti-idiotypic scFv antibodies of HM-1. After modified panning, 80% clones (40/50) showed several times higher binding affinity to nmAb-KT than regular panning. The major populations (48%) of these clones (scFv K1) were genotypically same and had strong cytocidal activity against Saccharomyces and Candida species. The scFv K1 (Kd value = 4.62 × 10-8 M) had strong reactivity toward nmAb-KT, like HM-1 (Kd value = 6.74 × 10-9 M) as judged by SPR analysis.ConclusionThe scFv antibodies generated after modified subtractive panning appear to have superior binding properties and cytocidal activity than regular panning. A simple modification of the elution condition in the phage-display panning protocol makes a large difference in determining success. Our method offers an attractive platform to discover potential therapeutic candidates.

Highlights

  • Phage-display panning is an integral part of biomedical research

  • Enrichment was determined to check the number of phages recaptured after each round of panning by counting the colony forming units (CFU) of the infected E. coli TG1

  • We successfully obtained recombinant single chain fragment variable (scFv) antibodies with high specificity against killer toxin neutralizing monoclonal antibody (nmAb-KT) directly from the phage-displayed scFv library of a hyper-immunized mouse

Read more

Summary

Introduction

Phage-display panning is an integral part of biomedical research. Regular panning methods are sometimes complicated by inefficient detachment of the captured phages from the antigen-coated solid supports, which prompted us to modify. The most common treatment for fungal infections is based on the use of amphotericin B, 5-flucytosine and fluconazole. These drugs have repeatedly failed against infections caused by Candida and Cryptococcus species [2]. BMC Biotechnology 2009, 9:99 http://www.biomedcentral.com/1472-6750/9/99 series of antigenic peptides from fungal pathogens have been identified that can generate immune responses, and which may assist in developing an antifungal vaccine [3,4]. To combat against fungal diseases, we are trying to produce a single, but general, antifungal vaccine by using an improved and optimized phage-display panning method that elicits immune responses in immunocompromised individuals who are at risk of invasive fungal infections by opportunistic fungal pathogens, as well as other multiple fungal infections

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call